SCHEDULE 13G
Statement of Beneficial Ownership
Aptevo Therapeutics Inc. Filed Acc 0001079973-25-000599
Stakes reported in this filing
Stake history · largest stake in each 13D and 13G
- 2026-11-16 SCHEDULE 13G/A · CVI Investments, Inc. 4.4%
- 2026-11-12 SCHEDULE 13G/A · Ayrton Capital LLC 3.72%
- 2026-08-14 SCHEDULE 13G/A · CVI Investments, Inc. 6.3%
- 2026-06-22 SCHEDULE 13G · NIOWAVE, INC. 12.2%
- 2026-02-17 SCHEDULE 13G/A · CVI Investments, Inc. 8.2%
- 2026-02-17 SCHEDULE 13G/A · Point72 Asset Management, L.P. 0%
- 2025-11-07 SCHEDULE 13G/A · BANK OF AMERICA CORP /DE/ 0.0%
- 2025-10-06 SCHEDULE 13G · BANK OF AMERICA CORP /DE/ 15.0%
- 2025-09-17 SCHEDULE 13G · Point72 Asset Management, L.P. 9.1%
- 2025-08-14 SCHEDULE 13G/A · CVI Investments, Inc. 9.9%
- 2025-08-14 SCHEDULE 13G/A · L1 Capital Global Opportunities Master Fund, Ltd. 4.99%
Loading xslSCHEDULE_13G_X01/primary_doc.xml…